Skip to content
HowShorted

Bed Bath & Beyond, Inc. short interest in 2024

In 2024, Bed Bath & Beyond, Inc.'s disclosed short interest ran from 11.25% of shares outstanding on 12 Jan 2024 to 18.86% on 31 Dec 2024, a change of +7.61 percentage points. The year's high was 18.86% on 31 Dec 2024 and its low 7.04% on 30 Apr 2024, averaging 12.00% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.81 days on 15 Feb 2024. Full history: Bed Bath & Beyond, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Bed Bath & Beyond, Inc. in 2024

2024 in figures

Start of year
11.25% (12 Jan 2024)
End of year
18.86% (31 Dec 2024)
Change
+7.61 pp
High
18.86% (31 Dec 2024)
Low
7.04% (30 Apr 2024)
Average
12.00%
Highest days to cover
4.81 (15 Feb 2024)
SEC filings marked
8

Every report in 2024

Bed Bath & Beyond, Inc. short interest in 2024
SettlementShort interestDays to coverFilings since previous
12 Jan 202411.25%4.31
31 Jan 202411.44%4.79
15 Feb 202410.60%4.81
29 Feb 202410.28%2.46results (8-K), 10-K filed
15 Mar 20248.15%3.22
28 Mar 20249.28%4.12
15 Apr 20248.49%1.92
30 Apr 20247.04%1.70
15 May 20248.33%1.13results (8-K), 10-Q filed
31 May 20247.76%2.39
14 Jun 202411.79%2.65
28 Jun 202412.55%2.97
15 Jul 202410.04%2.06
31 Jul 202410.63%1.78results (8-K), 10-Q filed
15 Aug 202412.39%2.17
30 Aug 202413.03%3.47
13 Sep 202413.91%3.51
30 Sep 202412.43%3.34
15 Oct 202413.85%4.09
31 Oct 202416.09%1.99results (8-K), 10-Q filed
15 Nov 202417.03%2.90
29 Nov 202416.68%3.35
13 Dec 202416.07%3.18
31 Dec 202418.86%2.95

See also: Bed Bath & Beyond, Inc.'s full history · most shorted US stocks of 2024 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.